View the LORAPLATZ registration information details.
Back to drug list
ItemsDrug Registration information
ID1652
No1652
Brand NameLORAPLATZ
IngredientsLORLATINIB 100 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size30 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE OR ROSI POSITIVE METASTATIC NON SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionYELLOW TABLET WITH 100 ON ONE SIDE AND PLAIN ON THE OTHER SIDE
Note
License OwnerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
ManufacturerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 L 0956/23
FDD Registration Date17/06/2025
Expiry Date16/06/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA